Activities per year
Activities
- 1 - 50 out of 59 results
Search results
-
Histoire de l'enseignement de la médecine en Belgique
Simon Absil (Speaker)
15 Jun 2024Activity: Talk or presentation types › Oral presentation
-
Impact de l'estetrol sur la coagulation chez les femmes ménopausées
Marie Didembourg (Speaker)
28 Mar 2024Activity: Talk or presentation types › Oral presentation
-
17e Congrès de la Médecine Générale France (CMGF 2024)
Simon Absil (Speaker)
21 Mar 2024Activity: Talk or presentation types › Oral presentation
-
Prediction of venous thromboembolism risk associated with combined oral contraceptives: an exploratory model
Morimont, L. (Speaker) & Douxfils, J. (Speaker)
30 Nov 2023Activity: Talk or presentation types › Oral presentation
-
Navigating new regulations in biobanking for clinical studies and research projects
Douxfils, J. (Speaker)
4 Oct 2023Activity: Talk or presentation types › Oral presentation
-
Reconstruction d'épiderme en milieu animal-free
Poumay, Y. (Speaker)
16 Jun 2023Activity: Talk or presentation types › Oral presentation
-
Prediction Of Venous Thromboembolism Risk Associated With Combined Oral Contraceptives: An Exploratory Model
Morimont, L. (Speaker)
19 May 2023Activity: Talk or presentation types › Oral presentation
-
Fantastic 4 - E4stetrol in Women's Health
Douxfils, J. (Invited speaker) & Foidart, J.-M. (Invited speaker)
4 May 2023 → 6 May 2023Activity: Talk or presentation types › Oral presentation
-
NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study
Morimont, L. (Speaker)
27 Apr 2023Activity: Talk or presentation types › Oral presentation
-
Acquired APC resistance as a marker for VTE, how does the estrogens differ?
Douxfils, J. (Invited speaker)
24 Mar 2023Activity: Talk or presentation types › Oral presentation
-
Low thrombin generation in menopausal women using Estetrol (E4)
Morimont, L. (Speaker)
27 Oct 2022Activity: Talk or presentation types › Oral presentation
-
Low Thrombin Generation in Menopausal Women Using Estetrol (E4)
Morimont, L. (Speaker) & Douxfils, J. (Speaker)
26 Oct 2022Activity: Talk or presentation types › Oral presentation
-
Affinity Capillary Electrophoresis in Fragment-Based Drug Discovery Projects, a Tool for Hit Discovery and Binding Site Characterization
DAVOINE, C. (Speaker)
4 Jul 2022Activity: Talk or presentation types › Oral presentation
-
Correlation between activated protein C Resistance and the Relative Risk of Venous Thromboembolism in Women Using Hormonal Therapy
Morimont, L. (Speaker) & Douxfils, J. (Speaker)
11 May 2022 → 14 May 2022Activity: Talk or presentation types › Oral presentation
-
Estetrol (E4): a native estrogen whose effect on the liver does not need to be counterbalanced by progestins
Douxfils, J. (Speaker)
27 May 2022Activity: Talk or presentation types › Oral presentation
-
Correlation between activated protein C Resistance and the Relative Risk of Venous Thromboembolism in Women Using Hormonal Therapy
Morimont, L. (Speaker)
11 May 2022 → 14 May 2022Activity: Talk or presentation types › Oral presentation
-
Thérapie hormonale et thromboembolie veineuse – Rôle et évaluation de la résistance à la protéine C activée
Morimont, L. (Speaker)
17 May 2022Activity: Talk or presentation types › Oral presentation
-
Combined oral contraceptives (COC) and venous thromboembolism (VTE): role and evaluation of activated protein C resistance
Morimont, L. (Speaker)
28 Apr 2022Activity: Talk or presentation types › Oral presentation
-
Evènements cardiovasculaires occlusifs associés aux inhibiteurs de tyrosine kinase ciblant BCR-ABL: Identification, compréhension et prédiction.
Haguet, H. (Speaker)
11 Feb 2022Activity: Talk or presentation types › Oral presentation
-
Assessment of the thrombotic risk associated with IVF treatment
Morimont, L. (Speaker)
10 Sept 2021Activity: Talk or presentation types › Oral presentation
-
Early subclinical cardiovascular changes after radiotherapy detected by echocardiography in women with breast cancer: contribution of the MEDIRAD EARLY-HEART cohort
Locquet, M. (Speaker)
2021Activity: Talk or presentation types › Oral presentation
-
Short term decline in muscle function is associated with mortality in the SarcoPhAge study
Locquet, M. (Speaker)
2020Activity: Talk or presentation types › Oral presentation
-
A new algorithm based on thrombin generation to assess hormone-relatedprothrombotic changes
Douxfils, J. (Invited speaker)
9 Jul 2019Activity: Talk or presentation types › Oral presentation
-
Clinical Debate: There is a need for DOAC testing in emergency situations and elective preoperative setting - YES
Douxfils, J. (Invited speaker)
14 Jun 2019Activity: Talk or presentation types › Oral presentation
-
Laboratory testing in patients treated with DOACs: a practical guide for clinicians
Douxfils, J. (Invited speaker)
20 Jun 2019Activity: Talk or presentation types › Oral presentation
-
Affections thromboemboliques veineuses – partie II
Douxfils, J. (Keynote speaker)
12 Mar 2019Activity: Talk or presentation types › Oral presentation
-
Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
21 Mar 2019Activity: Talk or presentation types › Oral presentation
-
Bone health assessment in older people with or without muscle health impairment
Locquet, M. (Speaker)
2019Activity: Talk or presentation types › Oral presentation
-
Belgian College of Neuropsychopharmacology and Biological Psychiatry, annual symposium
Desseilles, M. (Speaker)
14 Dec 2018Activity: Talk or presentation types › Oral presentation
-
Interference of DOACs in coagulation tests
Douxfils, J. (Invited speaker)
9 Nov 2018Activity: Talk or presentation types › Oral presentation
-
Educational I - Should we measure DOACs?
Douxfils, J. (Invited speaker)
22 Nov 2018Activity: Talk or presentation types › Oral presentation
-
Risques thrombotiques des produits dérivéssanguinsRevue de la littérature
Wannez, A. (Speaker)
29 Mar 2018Activity: Talk or presentation types › Oral presentation
-
Nanoparticules dans les peintures : quels risques pour la santé?
Laloy, J. (Speaker)
23 Mar 2018Activity: Talk or presentation types › Oral presentation
-
DOACs: new test on development
Douxfils, J. (Speaker)
2 Mar 2018Activity: Talk or presentation types › Oral presentation
-
Spin-off et financement - Présentation de QUALIblood
Gheldof, D. (Speaker) & Douxfils, J. (Speaker)
6 Mar 2018Activity: Talk or presentation types › Oral presentation
-
In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions
Haguet, H. (Speaker), Douxfils, J. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker), Mullier, F. (Speaker) & Dogne, J.-M. (Speaker)
9 Feb 2018Activity: Talk or presentation types › Oral presentation
-
Nanoparticules dans les peintures: quels risques pour la santé?
Laloy, J. (Speaker)
2018Activity: Talk or presentation types › Oral presentation
-
Three year adverse health consequences of sarcopenia in community dwelling older adults according to five diagnosis definitions
Locquet, M. (Speaker)
2018Activity: Talk or presentation types › Oral presentation
-
Réunion des tuteurs de Stage en médecine Générale - La réforme des études de bachelier en médecine
Marchand, É. (Speaker)
18 Oct 2017Activity: Talk or presentation types › Oral presentation
-
Assessment of thrombin generation in plasma samples of patients under anticoagulant treatment with ST Genesia system using STG – DrugScreen
Douxfils, J. (Speaker)
29 Jun 2017Activity: Talk or presentation types › Oral presentation
-
JOURNÉE DES PROJETS PUNCH- Classe inversée en Faculté de Médecine
Marchand, É. (Speaker)
16 May 2017Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
25 Feb 2017Activity: Talk or presentation types › Oral presentation
-
Bone quality assessment among sarcopenic and non sarcopenic elderly subjects from the SarcoPhAge study
Locquet, M. (Speaker)
2017Activity: Talk or presentation types › Oral presentation
-
Comparison of the performance of screening methods for sarcopenia
Locquet, M. (Speaker)
2017Activity: Talk or presentation types › Oral presentation
-
A GOLD 3 COPD patient "cured" by endobronchial valves
Marchand, É. (Speaker)
2 Dec 2016Activity: Talk or presentation types › Oral presentation
-
Analysis of extracellular vesicles derived from blood by flow cytometry
Wannez, A. (Speaker)
27 May 2016Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
28 Apr 2016Activity: Talk or presentation types › Oral presentation
-
Hémoglobinurie paroxystique nocturne: un modèle de la thrombogénicité
Wannez, A. (Speaker)
28 Apr 2016Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
29 Jan 2016Activity: Talk or presentation types › Oral presentation
-
Extracellular vesicle and platelet analysis by flow cytometry
Wannez, A. (Speaker)
2016Activity: Talk or presentation types › Oral presentation